| Molecular formula | C35H59N11O10 |
| Molecular weight | 793.9 g/mol |
| Registered trials | 0 |
| PubChem CID | 133082488 |
What N-Acetyl Selank Is
N-Acetyl Selank is a synthetic peptide compound with no FDA-approved label and no approved medical use. It has the molecular formula C35H59N11O10 and a molecular weight of approximately 793.9 g/mol (PubChem CID 133082488). It is classified here as an unapproved research compound, meaning it has not been evaluated or authorized by regulatory agencies for use in humans.
Clinical Trial Footprint
There are currently no registered clinical trials for N-Acetyl Selank. This means there is no publicly tracked record of the compound being studied in a formal clinical trial setting.
FAQ
No. N-Acetyl Selank has no FDA-approved label and is classified as an unapproved research compound. It has not been evaluated by regulatory agencies for safety or effectiveness in humans.
No clinical trials for N-Acetyl Selank are currently registered. There is no public trial record documenting its study in human subjects.
N-Acetyl Selank has the molecular formula C35H59N11O10 and a molecular weight of about 793.9 g/mol. It is catalogued in PubChem under CID 133082488.
No side effect or adverse event report data is currently available for N-Acetyl Selank. Without an approved label or trial history, no such information has been compiled.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem CID 133082488 ClinicalTrials.gov registry search
Updated 2026-11-14